Abstract
Fetal alcohol spectrum disorders (FASDs) are a common cause of intellectual impairment and birth defects. More recently, prenatal alcohol exposure (PAE) has been found to be a risk factor for fetal mortality, stillbirth and infant and child mortality. This has led to increased concern about detection and management of PAE. One to 2 h after maternal ingestion, fetal blood alcohol concentrations (BACs) reach levels nearly equivalent to maternal levels. Ethanol elimination by the fetus is impaired because of reduced metabolic capacity. Fetal exposure time is prolonged owing to the reuptake of amniotic-fluid containing ethanol by the fetus. Alcohol elimination from the fetus relies on the mother's metabolic capacity. Metabolic capacity among pregnant women varies eightfold (from 0.0025 to 0.02 g dl−1 h−1), which may help explain how similar amounts of ethanol consumption during pregnancy results in widely varying phenotypic presentations of FASD. At birth physiological changes alter the neonate's metabolic capacity and it rapidly rises to a mean value of 83.5% of the mother's capacity. FASDs are highly recurrent and younger siblings have increased risk. Detection of prenatal alcohol use offers an important opportunity for office-based interventions to decrease exposure for the remainder of pregnancy and identification of women who need substance abuse treatment. Mothers of children with FAS have been found to drink faster, get drunk quicker and to have higher BACs. A modest increase in the prevalence of a polymorphism of alcohol dehydrogenase, which increases susceptibility to adverse outcomes from PAE has been reported. Lastly, detection of alcohol use and appropriate management would decrease risk from PAE for subsequent pregnancies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Floyd RL, Sidhu JS . Monitoring prenatal alcohol exposure. Am J Med Genet C Semin Med Genet 2004; 127 (1): 3–9.
Henshaw SK . Unintended pregnancy in the United States. Fam Plann Perspect 1998; 30 (1): 24–29, 46.
May PA, Gossage JP, Kalberg WO, Robinson LK, Buckley D, Manning M et al. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev 2009; 15 (3): 176–192.
Sampson PD, Streissguth AP, Bookstein FL, Little RE, Clarren SK, Dehaene P et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology 1997; 56 (5): 317–326.
Abel EL . Fetal Alcohol Abuse Syndrome. Plenum Press: New York, 1998.
Burd LJ, Roberts D, Olson M, Odendaal H . Ethanol and the placenta: a review. J Matern Fetal Neonatal Med 2007; 20 (5): 361–375.
de la Monte SM, Wands JR . Role of central nervous system insulin resistance in fetal alcohol spectrum disorders. J Popul Ther Clin Pharmacol 2010; 17 (3): e390–e404.
Hannigan JH, Armant DR . Alcohol in pregnancy and neonatal outcome. Semin Neonatol 2000; 5 (3): 243–254.
Cornman-Homonoff J, Kuehn D, Aros S, Carter TC, Conley MR, Troendle J et al. Heavy prenatal alcohol exposure and risk of stillbirth and preterm delivery. J Matern Fetal Neonatal Med; e-pub ahead of print 5 July 2011.
Waltman R, Iniquez ES . Placental transfer of ethanol and its elimination at term. Obstet Gynecol 1972; 40 (2): 180–185.
Jung AL, Roan Y, Temple AR . Neonatal death associated with acute transplacental ethanol intoxication. Am J Dis Child 1980; 134 (4): 419–420.
Pizon AF, Becker CE, Bikin D . The clinical significance of variations in ethanol toxicokinetics. J Med Toxicol 2007; 3 (2): 63–72.
Gemma S, Vichi S, Testai E . Metabolic and genetic factors contributing to alcohol induced effects and fetal alcohol syndrome. Neurosci Biobehav Rev 2007; 31 (2): 221–229.
Khaole NCO, Ramchandani V, Viljoen D, Li T . A pilot study of alcohol exposure and pharmacokinetics in women with or without children with fetal alcohol syndrome. Alcohol Alcohol 2004; 39 (6): 503–508.
Zakhari S . Overview: how is alcohol metabolized by the body? Alcohol Res Health 2006; 29 (4): 245–254.
Rasheed A, Hines RN, McCarver May DG . Variation in induction of human placental CYP2E1: possible role in susceptibility to fetal alcohol syndrome? Toxicol Appl Pharmacol 1997; 144 (2): 396–400.
Dossevi L, Marfaing-Jallat P, Campfield LA, Le Magnen J . Blood removal and renal elimination of a constant dose of ethanol as a function of volumes and concentrations of solutions administered to rats. Pharmacol Biochem Behav 1983; 18 (3): 333–339.
Idanpaan-Heikkila J, Jouppila P, Akerblom HK, Isoaho R, Kauppila E, Koivisto M . Elimination and metabolic effects of ethanol in mother, fetus, and newborn infant. Am J Obstet Gynecol 1972; 112: 387–393.
Jelski W, Szmitkowski M . Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. Clin Chim Acta 2008; 395 (1–2): 1–5.
Karl PI, Gordon BH, Lieber CS, Fisher SE . Acetaldehyde production and transfer by the perfused human placental cotyledon. Science 1988; 242 (4876): 273–275.
Bearer CF, Santiago LM, O'riordan MA, Buck K, Lee SC, Singer LT . Fatty Acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J Pediatr 2005; 146 (6): 824–830.
Lieber CS, DeCarli LM . Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo. J Biol Chem 1970; 245 (10): 2505–2512.
Pikkarainen PH . Metabolism of ethanol and acetaldehyde in perfused human fetal liver. Life Sci II 1971; 10 (23): 1359–1364.
Hakkola J, Pelkonen O, Pasanen M, Raunio H . Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit Rev Toxicol 1998; 28 (1): 35–72.
Pelkonen O . Biotransformation of xenobiotics in the fetus. Pharmacol Ther 1980; 10 (2): 261–281.
Carpenter SP, Lasker JM, Raucy JL . Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol Pharmacol 1996; 49 (2): 260–268.
Gilbert WM . Amniotic fluid dynamics. NeoReviews 2006; 7 (6): 292–295.
Brien JF, Loomis CW, Tranmer J, McGrath M . Disposition of ethanol in human maternal venous blood and amniotic fluid. Am J Obstet Gynecol 1983; 146 (2): 181–186.
Gow PJ, Ghabrial H, Smallwood RA, Morgan DJ, Ching MS . Neonatal hepatic drug elimination. Pharmacol Toxicol 2001; 88 (1): 3–15.
Aperia A, Broberger O, Broberger U, Herin P, Zetterstrom R . Glomerular tubular balance in preterm and fullterm infants. Acta Paediatr Scand Suppl 1983; 305: 70–76.
Aperia A, Broberger O, Herin P, Thodenius K, Zetterstrom R . Postnatal control of water and electrolyte homeostasis in pre-term and full-term infants. Acta Paediatr Scand Suppl 1983; 305: 61–65.
Odendaal HJ, Steyn DW, Elliott A, Burd LJ . Combined effects of cigarette smoking and alcohol consumption on perinatal outcome. Gynecol Obstet Invest 2009; 67 (1): 1–8.
Altura BM, Carella A, Chatterjee M, Halevy S, Tejani N . Alcohol produces spasms of human umbilical blood vessels: relationship to fetal alcohol syndrome (FAS). Eur J Pharmacol 1982; 86 (2): 311–312.
Seppala M, Raiha NC, Tamminen V . Ethanol elimination in a mother and her premature twins. Lancet 1971; 1 (7710): 1188–1189.
Cook LN, Shott RJ, Andrews BF . Acute transplacental ethanol intoxication. Am J Dis Child 1975; 129 (9): 1075–1076.
Wagner L, Wagner G, Guerrero J . Effect of alcohol on premature newborn infants. Am J Obstet Gynecol 1970; 108 (2): 308–315.
Gartner U, Ryden G . The elimination of alcohol in the premature infant. Acta Paediatr Scand 1972; 61 (6): 720–721.
Beattie JO . Transplacental alcohol intoxication. Alcohol Alcohol 1986; 21 (2): 163–166.
Fuchs F, Fuchs AR, Poblete VF, Risk A . Effect of alcohol on threatened premature labor. Am J Obstet Gynecol 1967; 99 (5): 627–637.
Puschel K, Seifert H . Effects of alcohol in the embryo, fetus, and newborn infant (author's transl). Z Rechtsmed 1979; 83 (1): 69–76.
Acknowledgements
We gratefully acknowledge the expertise and effort of Ms Dawn Hackman from the University North Dakota Harley French Medical Library whose search expertise and tireless pursuit of the references made this paper possible.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Burd, L., Blair, J. & Dropps, K. Prenatal alcohol exposure, blood alcohol concentrations and alcohol elimination rates for the mother, fetus and newborn. J Perinatol 32, 652–659 (2012). https://doi.org/10.1038/jp.2012.57
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2012.57
Keywords
This article is cited by
-
Impact of low-level prenatal alcohol exposure and maternal stress on autonomic regulation
Pediatric Research (2024)
-
Longitudinal Relations Among Parental Substance Use Disorder and Adolescent Drinking Behavior: The Role of Temperament, Negative Urgency, and Maternal Parenting
Journal of Youth and Adolescence (2024)
-
Impact of alcohol exposure on neural development and network formation in human cortical organoids
Molecular Psychiatry (2023)
-
Gestational ethanol exposure impairs motor skills in female mice through dysregulated striatal dopamine and acetylcholine function
Neuropsychopharmacology (2023)
-
Potential Role of MANF, an ER Stress Responsive Neurotrophic Factor, in Protecting Against Alcohol Neurotoxicity
Molecular Neurobiology (2022)